Your browser does not support iframes.
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
IPSEN
(LES:
0MH6
)
27.62
EUR
UNCHANGED
Last Price
/ Updated:
10:47 AM EDT, Mar 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
26.00 (1000)
Ask (Size)
28.70 (1000)
Prev. Close
27.62
Today's Range
27.62 - 27.62
52wk Range
19.05 - 27.62
Shares Outstanding
84,118,423
Dividend Yield
2.90%
Top News
More News
Active Biotech and Ipsen update the analysis plan for the 10TASQ10 trial evaluating tasquinimod in the treatment of prostate cancer
April 25, 2013
from
Marketwired News Releases
Ipsen’s First Quarter 2013 Sales
April 25, 2013
from
Business Wire News Releases
More News
Read More
Ipsen expects Increlex® supply interruption due to supplier manufacturing issues
April 25, 2013
from
Business Wire News Releases
Active Biotech and Ipsen Update the Analysis Plan for the 10TASQ10 Trial Evaluating Tasquinimod in the Treatment of Prostate Cancer
April 25, 2013
from
Business Wire News Releases
Combined Shareholders’ Meeting of Ipsen on 31 May 2013: Proposals of Renewal of the Terms of Office of Two Directors and Appointment of a New Director
April 24, 2013
from
Business Wire News Releases
PeptiDream and Ipsen Enter into a Collaboration for Advancing Drug Discovery Efforts for Peptides to Treat Serious Disease
April 10, 2013
from
Business Wire News Releases
The Ipsen Group Publishes Its 2012 Registration Document
March 27, 2013
from
Business Wire News Releases
Ipsen and Inspiration Biopharmaceuticals announce closing of the sale of OBI-1 to Baxter International
March 21, 2013
from
Business Wire News Releases
Inspiration Biopharmaceuticals and Ipsen announce closing of the sale of OBI-1 (recombinant porcine factor VIII) to Baxter International
March 21, 2013
from
Business Wire News Releases
Christel Bories Joins Ipsen as Deputy Chief Executive Officer
February 27, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.